Thermo Fisher Scientific has received U.S. Food and Drug Administration (FDA) clearance for its ImmunoCap Specific Immunoglobulin E (IgE) Stinging Insect Allergen Components blood test.
The test analyzes a patient's sensitivity to up to eight different proteins found in bee and wasp venom that may cause anaphylaxis and other allergic symptoms, according to the company. Knowing specific risks can help identify culprit insects and sensitivity to bee and wasp venom, with potential to guide therapy and cut down on repeat anaphylaxis incidents associated with insect stings, Thermo Fisher suggested.
